Clinical Study: Type 1 Diabetes (T1D)
TrialNet Pathway to Prevention Study
TrialNet Diabetes Risk Screening is available and free to eligible family members of people with type 1 diabetes through an international research effort and BRI.
PI: Carla J Greenbaum, MD
Email: Diabetes@BenaroyaResearch.org
Phone: 800.888.4187
Benaroya Research Institute Awarded $4.1 Million National Institutes of Health Grant to Study Regulatory T Cells’ Function in Immune System Homeostasis
Read More
Science in Seattle: A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab
Read the publication ➡
Benaroya Research Institute’s Dr. Carla Greenbaum Receives Puget Sound Business Journal Lifetime Achievement Award
Read More
Two Teens, Two Clinical Trials, One Vision: Living Better With T1D
New Frontiers in Immunology: Studying Diseases in the Tissues Where They Happen
On the Brink of a Golden Age of Medicine
Study Summary
TrialNet is screening relatives of people with type 1 diabetes to find out if these family members are at risk for developing diabetes. Relatives of people with type 1 diabetes have about a three to four percent chance of testing positive for autoantibodies associated with diabetes.
If you learn you are at risk for developing type 1 diabetes, additional tests will be offered to estimate your chances of developing type 1 diabetes. If you qualify, you may have an opportunity to enroll in a prevention trial. All research volunteers will be closely monitored for early detection of type 1 diabetes. Early detection of type 1 diabetes may improve your blood sugar control and reduce your chances of developing complications. You will be part of a research program that may help other people at risk for type 1 diabetes.
Eligibility Criteria
The following people may be eligible:
- Individuals who are 2.5-45 years of age with a parent, child, brother or sister with type 1 diabetes
- Individual who are 2.5-20 years of age with a niece, nephew, aunt, uncle, grandparent, half-sibling or cousin with type 1 diabetes
Note: A relative diagnosed before the age of 40 AND started on insulin within the first year of diagnosis may have type 1 diabetes.
What will study participants be asked to do?
Screening involves a simple blood test for the presence of diabetes-related autoantibodies that may appear years before type 1 diabetes symptoms develop. TrialNet has established screening sites throughout North America.
